Navigation Links
Fenwal, GenesisBPS Enter Agreement for Blood-Specialty Products
Date:1/18/2011

LAKE ZURICH, Ill. and HACKENSACK, N.J., Jan. 18, 2011 /PRNewswire/ -- Fenwal, Inc. of Lake Zurich, Illinois, and GenesisBPS of Hackensack, N.J., announced today they have signed an agreement under which Fenwal will co-market and distribute a range of Genesis-branded products for blood centers, plasma centers and hospitals in the United States and Canada.

The agreement covers products such as Genesis™ blood collection mixers and monitors, RapidSeal II™ tube sealers and automated plasma expressers. Genesis products are designed to help operators improve precision and accuracy in the collection, separation, preparation and storage of blood components.

Fenwal is a global medical technology company focused on improving blood collection, separation, safety and availability. It offers the broadest range of technologies and supplies used in blood collection and transfusion medicine.

"This agreement further expands the Fenwal product offering and enhances the value we bring blood and plasma centers in North America," said Dean Gregory, Fenwal senior vice president of Commercial Operations.

"Fenwal brings high standards for service excellence and extensive knowledge in serving blood and plasma centers," said Adam Grossman, executive vice president of GenesisBPS. "Customers will benefit from the enhanced support and one-stop convenience this partnership creates."

Fenwal will exclusively market and distribute GenesisBPS products to community blood centers and plasma collection centers. GenesisBPS will market and distribute direct to the American Red Cross and U.S. government organizations, and both companies will service hospital accounts.

About Fenwal

Fenwal, Inc. is a global medical technology company focused on improving blood collection, filtration, separation, storage and transfusion to ensure the availability, safety and effectiveness of blood components. Fenwal is unique in the depth of its experience and commitment to transfusion medicine. The company offers the broadest range of products for the automated and manual collection of blood and blood components. Fenwal became an independent company in 2007, but its roots go back to 1949 with the founding of Fenwal Laboratories. Fenwal developed the first flexible, single-use container for blood collection, eliminating complications associated with glass containers and allowing blood to be separated into therapeutic components. Today, the company's products and advanced collection and separation technologies are used to help treat patients on six continents. Fenwal, Inc. is based in Lake Zurich, Illinois. For more information, please visit www.fenwalinc.com.

About GenesisBPS

GenesisBPS provides a complete range of blood specialty products designed to meet the unique and demanding needs of blood collection and processing organizations worldwide. The company focuses on the collection, processing, storage and preparation of blood, blood components and fluids. The Genesis product line includes Genesis™ Blood Collection Mixers and Monitors, Rapid-Seal II™ Tube Sealers, the TCD™ Sterile Tube Welder, PedI-Pak™ pediatric transfusion products, as well as a complete line of ancillary products and supplies. GenesisBPS is based in Hackensack, N.J. For more information, please visit www.genesisbps.com.


'/>"/>
SOURCE Fenwal, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Papastavros Opens New Radiology Centers in Delaware
2. EDC Functionality, Ease of Data Entry, and Access to Data All Factors in University of Virginia Cancer Centers Selection of the OnCore Clinical Research Management System
3. Resolvyx Pharmaceuticals and Celtic Therapeutics Enter Final Agreement in Ophthalmology
4. Key Equipment Finance Enters Long-Term Program Agreement With Hitachi Medical Systems America
5. Saints Medical Center and ZOLL Medical Corporation Enter Collaborative Agreement
6. The Center for Business Intelligence (CBI) Announces Virtual Conference on Imaging for Drug Development
7. Golden Meditech as First Chinese Healthcare Enterprise to Obtain Approval for Taiwan Depositary Receipts Offering
8. New URAC Program to Guide Practices as They Transform Themselves into Patient Centered Health Care Homes Now Available
9. Pfizer Animal Health to Acquire Synbiotics Corporation, Entering Diagnostics Sector
10. Sinovac Receives SFDA Approval to Commence Clinical Trials for Inactivated Enterovirus Type 71 Vaccine
11. InfraReDx Awarded 2010 Tax Incentive From Massachusetts Life Sciences Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Belgium , June 24, 2016 ... today announced the appointment of Dr. Edward ... as a Non-Executive Director, effective June 23, 2016.Dr. ... Compensation and Nominations and Governance Committees.  As a ... will provide independent expertise and strategic counsel to ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
Breaking Medicine Technology:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Pixel Film ... Pro X. , "Film editors can give their videos a whole new perspective by ... Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 ...
(Date:6/26/2016)... ... ... legally blind and certified personal trainer is helping to develop a weight loss fitness plan ... fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
Breaking Medicine News(10 mins):